Investor Fact Sheet

We aim to make a contribution to the evolution of scientific research using our skills, technology and experience to find solutions to the world’s most complex challenges.We harness the power of science and technology to  deliver integrated innovation with pace and efficiency across a diverse range of scientific domains. By providing access to the latest technology and highly trained scientists, underpinned by our values of integrity, excellence and professionalism, our aim is to be a trusted partner for clients seeking to explore the boundaries of science at affordable cost. Our services span the value chain from discovery to the clinic. Beyond the science, our strengths lie in our relentless pursuit of operational excellence; flexible business models; investment in data integrity; and passion for quality. We are proud to have partnerships that are deeply founded and nurtured over the years, delivering a level of commitment and understanding that drives innovation and scientific advances, thus linking our success to that of our clients and the people and patients they serve.

Key Figures (Consolidated, INR Million)

FY16
FY17
FY18
FY19
FY20
Revenue from operations
11,070
12,009
14,231
18,256
20,119
Other Income
63
707
618
751
816
Total income
11,133
12,716
14,849
19,007
20,935
Total expenses
7,266
7,933
9,583
12,888
13,940
EBITDA
3,867
4,783
5,266
6,119
6,995
EBITDA Margin %
35
38
35
32
33
Depreciation
973
1,143
1,314
1,642
2,193
Finance Cost
84
175
227
323
346
Profit Before Tax
2,810
3,465
3,725
4,154
4,456
Tax
402
592
671
838
794
Profit After Tax before exceptional items
2,408
2,873
3,054
3,316
3,662
Exceptional Items (net of tax)
459
Profit After Tax after exceptional items
2,408
2,873
3,054
3,316
4,121
Earning per share (INR) (Diluted)
12.19
14.55
15.43
16.67
10.35
Total Paid up Share Capital
2,000
2,000
2,000
2,000
4,000
Bonus Declared
1:1
Net cash from operating activities
3,081
3,977
4,462
6,304
6,771
Net cash from investing activities
-7,512
-4,691
-3,493
-6,465
-4,284
Net cash from financing activities
7,161
-808
-787
-724
-2,255
Cash and cash equivalents at the end of the year
3,873
2,345
2,527
1,652
1,930
Dividend Per Share (incl. interim and final dividends)
1.00
0.50
1.00